N S Majhail

Summary

Affiliation: National Marrow Donor Program
Country: USA

Publications

  1. pmc Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors
    Theresa Hahn
    National Marrow Donor Program, Minneapolis, MN 55413, USA
    J Clin Oncol 31:2437-49. 2013
  2. doi request reprint Racial disparities in hematopoietic cell transplantation in the United States
    N S Majhail
    National Marrow Donor Program, Minneapolis, MN 55413, USA
    Bone Marrow Transplant 47:1385-90. 2012
  3. pmc Costs of autologous and allogeneic hematopoietic cell transplantation in the United States: a study using a large national private claims database
    N S Majhail
    Center for International Blood and Marrow Transplant Research, Minneapolis, MN 55413, USA
    Bone Marrow Transplant 48:294-300. 2013
  4. pmc Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation
    N S Majhail
    National Marrow Donor Program, Minneapolis, MN 55413 1753, USA
    Hematol Oncol Stem Cell Ther 5:1-30. 2012
  5. pmc Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation
    N S Majhail
    National Marrow Donor Program, Broadway Street NE, Minneapolis, MN 55413 1753, USA
    Bone Marrow Transplant 47:337-41. 2012
  6. pmc Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation
    Navneet S Majhail
    National Marrow Donor Program, Minneapolis, Minnesota 55413 1753, USA
    Biol Blood Marrow Transplant 18:348-71. 2012
  7. pmc Outcomes of allogeneic hematopoietic cell transplantation for adolescent and young adults compared with children and older adults with acute myeloid leukemia
    Navneet S Majhail
    National Marrow Donor Program and Center for International Blood and Marrow Transplant Research, Minneapolis, MN 55413, USA
    Biol Blood Marrow Transplant 18:861-73. 2012
  8. doi request reprint A modified comorbidity index for hematopoietic cell transplantation
    T E DeFor
    Biostatistics and Informatics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA
    Bone Marrow Transplant 45:933-8. 2010
  9. pmc High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CR
    N S Majhail
    Center for International Blood and Marrow Transplant Research, Minneapolis, MN 55455, USA
    Bone Marrow Transplant 46:385-92. 2011
  10. doi request reprint Reduced-intensity hematopoietic cell transplantation in older patients with AML/MDS: umbilical cord blood is a feasible option for patients without HLA-matched sibling donors
    N S Majhail
    Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN 55455, USA
    Bone Marrow Transplant 47:494-8. 2012

Detail Information

Publications17

  1. pmc Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors
    Theresa Hahn
    National Marrow Donor Program, Minneapolis, MN 55413, USA
    J Clin Oncol 31:2437-49. 2013
    ..This study describes changes in use, technique, and survival in a population-based cohort...
  2. doi request reprint Racial disparities in hematopoietic cell transplantation in the United States
    N S Majhail
    National Marrow Donor Program, Minneapolis, MN 55413, USA
    Bone Marrow Transplant 47:1385-90. 2012
    ..Better understanding of racial disparities will minimize inequities, inform health policy, guide development of interventions targeted to eliminate disparities and ensure equitable access to HCT for all populations...
  3. pmc Costs of autologous and allogeneic hematopoietic cell transplantation in the United States: a study using a large national private claims database
    N S Majhail
    Center for International Blood and Marrow Transplant Research, Minneapolis, MN 55413, USA
    Bone Marrow Transplant 48:294-300. 2013
    ..Our study lays the foundation for using claims data for future research on economic aspects of HCT...
  4. pmc Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation
    N S Majhail
    National Marrow Donor Program, Minneapolis, MN 55413 1753, USA
    Hematol Oncol Stem Cell Ther 5:1-30. 2012
    ..This review provides the updated recommendations for screening and preventive practices for pediatric and adult survivors of autologous and allogeneic HCT...
  5. pmc Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation
    N S Majhail
    National Marrow Donor Program, Broadway Street NE, Minneapolis, MN 55413 1753, USA
    Bone Marrow Transplant 47:337-41. 2012
    ..This report provides the updated recommendations for screening and preventive practices for pediatric and adult survivors of autologous and allogeneic HCT...
  6. pmc Recommended screening and preventive practices for long-term survivors after hematopoietic cell transplantation
    Navneet S Majhail
    National Marrow Donor Program, Minneapolis, Minnesota 55413 1753, USA
    Biol Blood Marrow Transplant 18:348-71. 2012
    ..This review provides the updated recommendations for screening and preventive practices for pediatric and adult survivors of autologous and allogeneic HCT...
  7. pmc Outcomes of allogeneic hematopoietic cell transplantation for adolescent and young adults compared with children and older adults with acute myeloid leukemia
    Navneet S Majhail
    National Marrow Donor Program and Center for International Blood and Marrow Transplant Research, Minneapolis, MN 55413, USA
    Biol Blood Marrow Transplant 18:861-73. 2012
    ..The risk of relapse did not change over time. Improvements in survival among AYAs undergoing allogeneic HCT for AML have paralleled those among children and older adults...
  8. doi request reprint A modified comorbidity index for hematopoietic cell transplantation
    T E DeFor
    Biostatistics and Informatics Core, Masonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA
    Bone Marrow Transplant 45:933-8. 2010
    ..In conclusion, we are introducing the MCI which may have higher discriminating and predictive power for overall survival and NRM. Validation of the HCT-CI and the MCI in larger and separate cohorts of HCT recipients is still needed...
  9. pmc High probability of long-term survival in 2-year survivors of autologous hematopoietic cell transplantation for AML in first or second CR
    N S Majhail
    Center for International Blood and Marrow Transplant Research, Minneapolis, MN 55455, USA
    Bone Marrow Transplant 46:385-92. 2011
    ..Patients who receive autologous HCT for AML in CR1 or CR2 and remain in remission for ≥2 years have very favorable long-term survival. Their mortality rates are similar to that of the general population...
  10. doi request reprint Reduced-intensity hematopoietic cell transplantation in older patients with AML/MDS: umbilical cord blood is a feasible option for patients without HLA-matched sibling donors
    N S Majhail
    Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN 55455, USA
    Bone Marrow Transplant 47:494-8. 2012
    ..UCB is feasible as an alternative donor source for reduced-intensity conditioning HCT among older patients with AML and MDS who do not have a suitable MSD...
  11. doi request reprint Similar risks for hypothyroidism after allogeneic hematopoietic cell transplantation using TBI-based myeloablative and reduced-intensity conditioning regimens
    A Al-Hazzouri
    Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN 55455, USA
    Bone Marrow Transplant 43:949-51. 2009
    ..6 vs RIC). At least in the first few years after HCT, the risks for hypothyroidism are similar among patients receiving TBI-based MA and reduced-intensity regimens...
  12. pmc Impact of ABO-mismatch on risk of GVHD after umbilical cord blood transplantation
    R Romee
    Medicine, Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN, USA
    Bone Marrow Transplant 48:1046-9. 2013
    ..Whereas ABO-compatible donors are preferred in recipients of URD-HCT, ABO compatibility generally need not be considered in recipients of UCB-HCT. ..
  13. pmc High prevalence of metabolic syndrome after allogeneic hematopoietic cell transplantation
    N S Majhail
    Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN, USA
    Bone Marrow Transplant 43:49-54. 2009
    ..We conclude that metabolic syndrome occurs frequently among allogeneic HCT survivors who are seen by transplant physicians. Approaches to screening, prevention and management of metabolic syndrome should be developed for HCT recipients...
  14. pmc Pilot study of patient and caregiver out-of-pocket costs of allogeneic hematopoietic cell transplantation
    N S Majhail
    1 National Marrow Donor Program, Minneapolis, MN, USA 2 Center for International Blood and Marrow Transplant Research, Minneapolis, MN, USA
    Bone Marrow Transplant 48:865-71. 2013
    ..Our study lays the foundation for future research on the early and long-term financial impact of allogeneic HCT on patients/caregivers...
  15. doi request reprint Iron overload in hematopoietic cell transplantation
    N S Majhail
    Blood and Marrow Transplant Program, University of Minnesota, Minneapolis, MN 55455, USA
    Bone Marrow Transplant 41:997-1003. 2008
    ..Natural history, evolution and treatment of iron overload in transplant survivors have not been adequately investigated and more studies are needed to determine its impact on short-term and long-term morbidity and mortality...
  16. doi request reprint Screening, prevention and management of osteoporosis and bone loss in adult and pediatric hematopoietic cell transplant recipients
    B L McClune
    Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN, USA
    Bone Marrow Transplant 46:1-9. 2011
    ....
  17. ncbi request reprint Alveolar hemorrhage following allogeneic hematopoietic cell transplantation using reduced-intensity conditioning
    N S Majhail
    Blood and Marrow Transplant Program, Division of Hematology, Oncology and Transplantation, University of Minnesota, Minneapolis, MN 55455, USA
    Bone Marrow Transplant 38:765-8. 2006
    ..Reducing the intensity of preparative regimen does not protect against post transplant alveolar hemorrhage. Alveolar hemorrhage occurring after RIC or MAC HCT has similar incidence, clinical presentation, and associated high mortality...